Navigation Links


Lighting at Biology News

Moonlighting enzyme linked to neurodegenerative disease

Friedreich's ataxia is one of those diseases few have heard of unless you know someone with the condition. For that individual -- usually a child or teenager -- it is devastating. Symptoms are mild at first: muscle weakness in the arms and legs, vision impairment and slurred speech, but eventually the symptoms progress and most patients become wheelchair-bound and succumb to heart failure later i...

Lighting up life: Cold Spring Harbor Protocols presents tips for creating glowing plants

Just over a decade ago, biologists isolated a unique protein from jellyfish that could be inserted into other organisms—from to pigs—and cause them to radiate a brilliant green color. This green fluorescent protein (GFP) has allowed biologists to make many new discoveries regarding how living cells function. But one kingdom of life—plants—has presented special challenges to GFP det...
Lighting at Biology Products
Lighting at Biology Technology

Cooper Lighting picks RedPrairie solutions

The lighting manufacturer is replacing its nine-year-old t...
Lighting at Medicine News

Improving Lighting Could Bring About A Change In Alzheimer's Patients

A new experiment shows the effect lighting has on Alzheimer's patients. Based on their findings Alzheimer's patients were found to talk to each other more than usual and were also less anxious.// Studies in the past have shown that lighting improves mood and nature of Alzheimer’s patients hence researchers used this knowledge to make a dramatic change in an Alzheimer’s center . Researc...

'Winter Blues' Treated by Breakthrough Lighting Technology

Almost 10 to 12 million suffer from winter depression, of which 8 to 10 million are females from 17 to 35 years of age.// Current research indicates that the absence of sunlight triggers a biochemical reaction that may cause symptoms such as loss of energy, fatigue, lethargy, decreased activity, sadness, excessive eating, carbohydrate cravings and sleepiness. Individuals affected by "wi...
Lighting at Medicine Products

CHROMOPHARE Surgical Lighting

Description:The D-Series Plus from BERCHTOLD offers you a complete solution to surgical lighting. They're bright and cool, returning 98% of the bulb's original illumination to the surgical field and filtering 99% of the radiant energy. The light field is clear and color correct with a 31" depth of field and a neutral white color temperature of 4500 Kelvin, giving you accurate tissue rendition. A single...
Company:Berchtold Corporation

ALM PrismAlix® Lighting Systems

Description:Features exclusive micro-prism refractive technology that precisely focuses a column of evenly distributed light onto the surgical site. Patented prism based technology delivers an unmatched combination of cavity illumination, shadow control, heat management and true color representation. The highly maneuverable PrismAlix Series is available in a wide range of configurations, including wall and...
Company:Getinge USA, Inc.

NAUTILUS Series Fixed Focus Lighting

Description:The Next Generation in Single Lamp Technology, Advanced Optics & Reflector Design, Extended Depth of Field, 54" Useable Column of Light, High Intensity, Cool Beam Temperature...
Company:Skytron

STELLAR Series Surgical Lighting

Description:Advanced Lighting System with Multi-Lamp Design providing Surgeon Focus Control and Extended, Variable Depth of Field over greater working distances. High Intensity, Cool Beam Temperature...
Company:Skytron

Harmony™ Lux Advantage LA Surgical Lighting and Visualization System

Description:The newest STERIS lighting system for cutting edge ORs features intuitive controls, Wavelens™ technology for super-focus capability, a Cold Mirror Reflector for superior shadow control and depth of field, and an easy-to-replace lamp system with backup. The system's LCD control center compensates for fluctuations in power supply and performs self-diagnostics....
Company:STERIS Corporation

More>>

Lighting at Medicine Technology

Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Association's Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2007 - ElixirPharmaceuticals, Inc., today announced the presentation of two setsof preclinical data demonstrating that ghrelin antagonism may be apotential method for future treatment of a range of metabolicdisorders. These data demonstrated a variety of beneficialmetabolic effects, notably decreasing body weight, improvements inblood glucose and i...

Elixir Pharmaceuticals Announces Clinical Data at American Diabetes Association Conference Highlighting Ability of Glufast to Maintain Glycemic Control in Patients with Type 2 Diabetes

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2007 - ElixirPharmaceuticals, Inc., announced today the publication of clinicaldata highlighting the ability of Glufast(R) (mitiglinide calciumhydrate) monotherapy, or combination therapy with metformin, tomanage glucose surges before and after meals. The data werepublished in the Abstract Book for the American DiabetesAssociation 67th Annual Scien...

Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois

NEW YORK, June 22, 2007 /PRNewswire-FirstCall/ -- KeryxBiopharmaceuticals, Inc. today announced that abstracts related toSulonex(TM) (sulodexide oral gelcap) have been selected forpublication or presentation during the poster sessions scheduled totake place at the upcoming American Diabetes Association (ADA) 67thAnnual Scientific Sessions and exposition at the McCormick PlaceLakeside Cen...

OXiGENE Announces a Poster Presentation Highlighting Results from its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study MMD-213) at the 47th Annual Meeting of the Association of Research in Vision and Ophthalmology

WALTHAM, Mass.--(BUSINESS WIRE)--May 7, 2007 - OXiGENE, Inc.(NASDAQ: OXGN, XSSE: OXGN), a clinical-stage biotechnology companydeveloping novel therapeutics to treat cancer and eye diseases,announced today that the results of its Phase II combretastatin A4phosphate (CA4P) clinical trial in myopic macular degeneration(MMD) was presented at the 47th Annual Meeting of the Associationof Research...

ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR

LOS ANGELES--(BUSINESS WIRE)--Apr 17, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ZIOP) announced today the presentation of preclinicaldata strongly supportive of the development of an oral form ofZIO-101. Specifically, ZIO-101 demonstrates very highbioavailability when administered orally; in addition it evidencesanti-angiogenic activity that is particularly well suited to oraladministration. T...
Other TagsCodmanToothedMayfieldEndoscopeSwing
(Date:10/3/2008)...- Inc. Magazine recently included,Connolly Consult...ing,private companies in the country. The list is ...segment of the economy -- America,s,independent-mi...ies,represent the backbone of the U.S. economy., ...03/NY36880LOGO ), Connolly Consulting,s consiste...
(Date:10/3/2008)... Discrimination; Recognizes,Importance of Mental H.../PRNewswire-USNewswire/ -- Mental Health,America t...approval of a,mental health parity legislation tha...ion against Americans with mental health and subst...lans., The legislation, which recognizes the impo...
(Date:10/3/2008)...search Foundation(R) Collection of, Bouquets to T...Research, LOS ANGELES, Oct. 3 /PRNewswire/ -- Tel...g only hand-arranged, hand-delivered floral,arrang...nth-long,collaboration with The City of Hope, John... Cancer Center in southern California and national...
(Date:10/3/2008)...- As the population ages, a big,question employers...e the,financial crunch of an illness?", In most c...eck to,paycheck and now need two incomes to provid... spouses becomes critically ill and unable to work...ut the healthy,employee/spouse is strained by the ...
Breaking Medicine News(10 mins):Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2
(Date:10/3/2008)... a fish moves through water, which is why this liz...rows to about 15 cm long and lives in the deserts ...wn by the name "sandfish."Although it looks fairly...wo to teach materials-handling and process-technol...w the surface of the sand and moves through its el...
(Date:10/3/2008)... observance of Nuclear Medicine Week (October 5 to...ctober), SNM released today a new fact sheet highl...echnologies that are dramatically improving the wa.... , Molecular imaging is a highly effective, saf...ating breast cancer. Physicians report that the in...
(Date:10/3/2008)...Riverside-led team of biomedical scientists has fo...ne, used widely to treat acne and skin infections,...st common inherited cause of mental impairment and...findings have already impacted future therapies, w...o, Canada, that will test minocycline in patients ...
(Date:10/2/2008)...m their birthplace to their work site, they sequen...k of exceptionally strong proteins known as the ex...the October 3 issue of Cell , scientists at the H...versity show that a molecule, called ACF7, helps r...findings that could have implications for understa...
Breaking Biology News(10 mins):So-called 'sandfish' could help materials handling and process technology specialists 2So-called 'sandfish' could help materials handling and process technology specialists 3SNM releases new fact sheet on breast cancer and molecular imaging 2UCR researchers propose minocycline as a promising drug for patients with Fragile X syndrome 2UCR researchers propose minocycline as a promising drug for patients with Fragile X syndrome 3Scientists identify a molecule that coordinates the movement of cells 2Immunotec Inc announces appointment of President 26 CEO James A Northrop 1219 1Immunotec Inc announces appointment of President 26 CEO James A Northrop 1219 2AACR BCRF award inaugural grants in translational breast cancer research 772 1AACR BCRF award inaugural grants in translational breast cancer research 772 2AACR BCRF award inaugural grants in translational breast cancer research 772 3Nanoparticle exposures happen says expert 769 1Nanoparticle exposures happen says expert 769 2Scientists Spot Eyes Motion Sensors 3505 1Scientists Spot Eyes Motion Sensors 3505 2
Other Contentstropismbreedingbreedingbreedingbreedingtruetruetruetruetruetruetruetruetruefeetfeetfeetfeetfeetfeetfeetfeetsuppressorsuppressorsuppressorsuppressorsuppressorsuppressortunicatunicaturnoverturnoverturnoverturnoverturnoverturnover